Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland

Overview

Journal Clin Rev Allergy Immunol

Specialty Allergy & Immunology

Date 2017 Nov 29

PMID 29181702

Citations 8

Authors

Benedetta Terziroli Beretta-Piccoli

Guido Stirnimann

Andreas Cerny

David Semela

Roxane Hessler

Beat Helbling

Felix Stickel

Carolina Kalid-de Bakker

Florian Bihl

Emiliano Giostra

Magdalena Filipowicz Sinnreich

Carl Oneta

Adriana Baserga

Pietro Invernizzi

Marco Carbone

Joachim Mertens

Affiliations

Soon will be listed here.

Abstract

Trial Registration Number: clinicaltrials.gov : NCT02846896; SNCTP000001870.

Citing Articles

Incidence and prevalence of primary biliary cholangitis in the Netherlands - A nationwide cohort study.

de Veer R, van Hooff M, Werner E, Beuers U, Drenth J, Cuperus F JHEP Rep. 2024; 6(8):101132.

PMID: 39113899 PMC: 11304051. DOI: 10.1016/j.jhepr.2024.101132.

The Epidemiology of Primary Biliary Cholangitis in European Countries: A Systematic Review and Meta-Analysis.

Gazda J, Drazilova S, Janicko M, Jarcuska P Can J Gastroenterol Hepatol. 2021; 2021:9151525.

PMID: 34239845 PMC: 8238597. DOI: 10.1155/2021/9151525.

Changed Profile of Serum Transferrin Isoforms in Primary Biliary Cholangitis.

Grytczuk A, Bauer A, Gruszewska E, Cylwik B, Chrostek L J Clin Med. 2020; 9(9).

PMID: 32911601 PMC: 7564153. DOI: 10.3390/jcm9092894.

Factors influencing harmonized health data collection, sharing and linkage in Denmark and Switzerland: A systematic review.

Genevieve L, Martani A, Mallet M, Wangmo T, Elger B PLoS One. 2019; 14(12):e0226015.

PMID: 31830124 PMC: 6907832. DOI: 10.1371/journal.pone.0226015.

Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.

Galoosian A, Hanlon C, Tana M, Cheung R, Wong R Dig Dis Sci. 2019; 65(2):406-415.

PMID: 31489564 DOI: 10.1007/s10620-019-05809-x.

References

Mytilinaiou M, Meyer W, Scheper T, Rigopoulou E, Probst C, Koutsoumpas A . Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. Clin Chim Acta. 2012; 413(15-16):1211-6. DOI: 10.1016/j.cca.2012.03.020. View

Wong R, Lim S, Wee A, Chan Y, Aung M, Wai C . Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic population. J Gastroenterol Hepatol. 2007; 23(4):599-605. DOI: 10.1111/j.1440-1746.2007.05058.x. View

Floreani A, Franceschet I, Cazzagon N, Spinazze A, Buja A, Furlan P . Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol. 2014; 48(2-3):192-7. DOI: 10.1007/s12016-014-8427-x. View

Boonstra K, Kunst A, Stadhouders P, Tuynman H, Poen A, van Nieuwkerk K . Rising incidence and prevalence of primary biliary cirrhosis: a large population-based study. Liver Int. 2014; 34(6):e31-8. DOI: 10.1111/liv.12434. View

Kanth R, Shrestha R, Rai I, VanWormer J, Roy P . Incidence of Primary Biliary Cholangitis in a Rural Midwestern Population. Clin Med Res. 2017; 15(1-2):13-18. PMC: 5573520. DOI: 10.3121/cmr.2017.1351. View

Cheung K, Seto W, Fung J, Lai C, Yuen M . Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015. Clin Transl Gastroenterol. 2017; 8(8):e116. PMC: 5587844. DOI: 10.1038/ctg.2017.43. View

Gershwin M, Selmi C, Worman H, Gold E, Watnik M, Utts J . Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005; 42(5):1194-202. PMC: 3150736. DOI: 10.1002/hep.20907. View

Triger D . Primary biliary cirrhosis: an epidemiological study. Br Med J. 1980; 281(6243):772-5. PMC: 1714035. DOI: 10.1136/bmj.281.6243.772. View

Delgado J, Vodonos A, Delgado B, Jotkowitz A, Rosenthal A, Fich A . Primary biliary cirrhosis in Southern Israel: a 20 year follow up study. Eur J Intern Med. 2012; 23(8):e193-8. DOI: 10.1016/j.ejim.2012.09.004. View

10.

Boonstra K, Beuers U, Ponsioen C . Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol. 2012; 56(5):1181-1188. DOI: 10.1016/j.jhep.2011.10.025. View

11.

Koulentaki M, Mantaka A, Sifaki-Pistolla D, Thalassinos E, Tzanakis N, Kouroumalis E . Geoepidemiology and space-time analysis of Primary biliary cirrhosis in Crete, Greece. Liver Int. 2014; 34(7):e200-7. DOI: 10.1111/liv.12479. View

12.

Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari A, Coppel R . A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology. 2007; 45(3):659-65. DOI: 10.1002/hep.21583. View

13.

Griffiths L, Dyson J, Jones D . The new epidemiology of primary biliary cirrhosis. Semin Liver Dis. 2014; 34(3):318-28. DOI: 10.1055/s-0034-1383730. View

14.

Baldursdottir T, Bergmann O, Jonasson J, Ludviksson B, Axelsson T, Bjornsson E . The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study. Eur J Gastroenterol Hepatol. 2012; 24(7):824-30. DOI: 10.1097/MEG.0b013e328353753d. View

15.

Corpechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C . Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008; 48(3):871-7. DOI: 10.1002/hep.22428. View

16.

Carey E, Ali A, Lindor K . Primary biliary cirrhosis. Lancet. 2015; 386(10003):1565-75. DOI: 10.1016/S0140-6736(15)00154-3. View

17.

Prince M, Chetwynd A, Diggle P, Jarner M, Metcalf J, James O . The geographical distribution of primary biliary cirrhosis in a well-defined cohort. Hepatology. 2001; 34(6):1083-8. DOI: 10.1053/jhep.2001.29760. View

18.

Metcalf J, Bhopal R, Gray J, Howel D, James O . Incidence and prevalence of primary biliary cirrhosis in the city of Newcastle upon Tyne, England. Int J Epidemiol. 1997; 26(4):830-6. DOI: 10.1093/ije/26.4.830. View

19.

Lindor K, Gershwin M, Poupon R, Kaplan M, Bergasa N, Heathcote E . Primary biliary cirrhosis. Hepatology. 2009; 50(1):291-308. DOI: 10.1002/hep.22906. View

20.

Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M . Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology. 2006; 45(1):118-27. DOI: 10.1002/hep.21472. View